Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2025-12-26 @ 11:46 AM
Study NCT ID:
NCT05359016
Status:
RECRUITING
Last Update Posted:
2025-11-04
First Post:
2022-04-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Sponsor:
M.D. Anderson Cancer Center
Organization:
Study Overview
Official Title:
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Status:
RECRUITING
Status Verified Date:
2025-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.
Detailed Description:
Objectives:
The study objectives are outlined below:
1. To quantify the health impact of CCS\&PT on the uptake of voluntary FP services.
2. To quantify the health impact of voluntary FP on the uptake of CCS\&PT services.
3. To determine which promotional strategies are most effective to increase uptake of CCS\&PT services.
4. To identify cost to deliver high quality CCS\&PT services integrated into existing voluntary FP programs.
5. To determine client and provider acceptability of integrated CCS\&PT and voluntary FP services using new screen and treat technologies.
The study objectives are outlined below:
1. To quantify the health impact of CCS\&PT on the uptake of voluntary FP services.
2. To quantify the health impact of voluntary FP on the uptake of CCS\&PT services.
3. To determine which promotional strategies are most effective to increase uptake of CCS\&PT services.
4. To identify cost to deliver high quality CCS\&PT services integrated into existing voluntary FP programs.
5. To determine client and provider acceptability of integrated CCS\&PT and voluntary FP services using new screen and treat technologies.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| NCI-2022-03767 | OTHER | NCI-CTRP-Clinical Trial Reporting Registry | View |